Op
Open access platform aggregating clinical trials for Covid-19
Open access platform aggregating clinical trials for Covid-19
Share cardActual performance
11points
Made the leaderboard
Launch Intel predictions
Analyze your own launch →62%62% predicted probability of success on BetaList, based on ML models trained on real launch data.
best fitHighest predicted score across all platforms for this description.
47%47% predicted probability of success on AppSumo, based on ML models trained on real launch data.
46%46% predicted probability of success on Hacker News, based on ML models trained on real launch data.
nativeThis product was originally launched on this platform.
46%46% predicted probability of success on TrustMRR, based on ML models trained on real launch data.
41%41% predicted probability of success on Product Hunt, based on ML models trained on real launch data.
24%24% predicted probability of success on Indie Hackers, based on ML models trained on real launch data.
14%14% predicted probability of success on Acquire.com, based on ML models trained on real launch data.
Incorrect prediction on native model
Similar products
Dr
DrugSheet – Keep up with the clinical trials on Covid-1942%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
DrugSheet – Keep up with the clinical trials on Covid-19
Dr
DrugSheet – Keep up with the clinical trials on Covid-1942%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
DrugSheet – Keep up with the clinical trials on Covid-19
Re
Redis IaaS platform open sourced73%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Redis IaaS platform open sourced
Colony55%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Platform for open organizations
En
Endorsements for Open Access Research47%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Endorsements for Open Access Research
De
Democratizing Access to Hedge Funds47%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Democratizing Access to Hedge Funds
Alpacon18%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
All-in-one Server Access Platform for DevSecOps
DxNova46%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Platform for guided clinical assessment
TrialReviewer12%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Evidence Appraisal for Clinical Trials
Op
Open-access book on platform governance28%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Open-access book on platform governance